China National Medicines Corporation Ltd.
600511
Clasificación en acciones
#4879
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Precio por acción
$4.00
Capitalización bursátil
$3.02B
Cambio (1 día)
2.64%
Cambio (1 año)
-1.05%
País
CN
Comercio China National Medicines Corporation Ltd. (600511)
Categoría
Healthcare
Ingresos de China National Medicines Corporation Ltd. (600511)
Ingresos en Jun 2026 TTM: $7.76B
Según los últimos informes financieros de China National Medicines Corporation Ltd., los ingresos actuales de la empresa (TTM) son $7.76B. En 2023, la empresa obtuvo unos ingresos de $7.02B un aumento con respecto a los ingresos del año 2022, que fueron de $6.60B. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de China National Medicines Corporation Ltd. desde 2000 hasta 2026
Ingresos al final de cada año
| Año | Ingresos | Cambiar |
|---|---|---|
| 2026 (TTM) | $7.76B | 11.97% |
| 2024 | $6.93B | -1.26% |
| 2023 | $7.02B | 6.44% |
| 2022 | $6.60B | -9.78% |
| 2021 | $7.31B | 18.28% |
| 2020 | $6.18B | -3.59% |
| 2019 | $6.41B | 13.84% |
| 2018 | $5.63B | 0.99% |
| 2017 | $5.58B | 11.87% |
| 2016 | $4.99B | 168.02% |
| 2015 | $1.86B | -0.15% |
| 2014 | $1.86B | 12.08% |
| 2013 | $1.66B | 20.63% |
| 2012 | $1.38B | 23.34% |
| 2011 | $1.12B | 24.59% |
| 2010 | $896.61M | 17.84% |
| 2009 | $760.87M | 18.39% |
| 2008 | $642.69M | 31.31% |
| 2007 | $489.45M | 36.11% |
| 2006 | $359.59M | 24.36% |
| 2005 | $289.14M | 32.86% |
| 2004 | $217.63M | 22.35% |
| 2003 | $177.87M | 20.30% |
| 2002 | $147.86M | 0.22% |
| 2001 | $147.54M | 11.05% |
| 2000 | $132.86M | 0.00% |
Ingresos de empresas similares o competidoras
| Empresa | Ingresos | Diferencia de ingresos | País |
|---|---|---|---|
| $410.98B | 5,194.83% |
US
|
|
| - | - |
US
|
|
| $254.25B | 3,175.56% |
US
|
|
| - | - |
US
|
|
| $7.64B | -1.55% |
AU
|
